Cara Therapeutics, Inc. Annual Return On Assets in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Cara Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2014 to 2023.
  • Cara Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -112 %, a 41.2% decline year-over-year.
  • Cara Therapeutics, Inc. annual Return On Assets for 2023 was -89.6 %, a 122% decline from 2022.
  • Cara Therapeutics, Inc. annual Return On Assets for 2022 was -40.4 %, a 7.79% decline from 2021.
  • Cara Therapeutics, Inc. annual Return On Assets for 2021 was -37.5 %, a 973% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -89.6 -49.2 -122% Jan 1, 2023 Dec 31, 2023
2022 -40.4 -2.92 -7.79% Jan 1, 2022 Dec 31, 2022
2021 -37.5 -41.8 -973% Jan 1, 2021 Dec 31, 2021
2020 4.3 +56.4 Jan 1, 2020 Dec 31, 2020
2019 -52.1 -4.64 -9.78% Jan 1, 2019 Dec 31, 2019
2018 -47.4 +16 +25.3% Jan 1, 2018 Dec 31, 2018
2017 -63.5 +4.31 +6.36% Jan 1, 2017 Dec 31, 2017
2016 -67.8 -37.6 -124% Jan 1, 2016 Dec 31, 2016
2015 -30.2 -2.71 -9.85% Jan 1, 2015 Dec 31, 2015
2014 -27.5 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.